CASI Pharmaceuticals Inc (CASI) – Company Profile and SWOT Analysis
- Pages: 45
- Published: April 2025
- Report Code: MLPH56175FSA
CASI Pharmaceuticals Inc (CASI) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for treating cancer and other unmet medical needs. The company’s product EVOMELA (melphalan for injection) an intravenous formulation for the treatment of multiple myeloma. It’s pipeline product portfolio includes CID-103 for the treatment of multiple myeloma; CNTC-19 for hematological malignancies; BI-1206 for non-Hodgkin’s lymphoma and solid tumors; CB-5339 AML/MDS and solid tumors; Octreotide LAI for the treatment of acromegaly and symptoms associated with neuroendocrine tumors. It works with Spectrum Pharmaceuticals Inc, Acrotech, and Juventas Cell Therapy, among others, to develop and distribute its products. The company operates its subsidiaries in the US and China and a research and development center in Beijing, China. CASI is headquartered in Beijing, China.
Scope
Detailed information on CASI Pharmaceuticals Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting CASI Pharmaceuticals Inc in the form of a SWOT analysis
An in-depth view of the business model of CASI Pharmaceuticals Inc including a breakdown and examination of key business segments
News about CASI Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of CASI Pharmaceuticals Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess CASI Pharmaceuticals Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on CASI Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Cardiff Oncology Inc
Viva Biotech Holdings
Shanghai GeneChem Co Ltd
Hualan Biological Engineering Inc
Genentech USA Inc
Fennec Pharmaceuticals Inc
Zivo Bioscience Inc
Natsar Pharmaceuticals Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.